Human umbilical-cord-derived mesenchymal stem cells in combination with rapamycin reduce cartilage degradation via inhibition of the AKT/mTOR signaling pathway.

Immunopharmacology and immunotoxicology(2023)

Cited 0|Views4
No score
Abstract
Our study provides new evidence to support the use of hUMSCs in combination with rapamycin as a potential candidate for OA treatment.
More
Translated text
Key words
Human umbilical-cord-derived mesenchymal stem cells,combination therapy,mTOR signaling pathway,osteoarthritis,rapamycin
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined